Goal of the Program
- To improve patient care by the generation of new knowledge that improves patient care
- To improve patient care by the development of new diagnostics, biomarkers of disease, and novel treatments
Senad Divanovic, PhD
"Pathogenic Potential of Th17 Axis in NAFLD Severity"
Jaimie Nathan, MD
"Intestinal Microbiota in Children with Chronic Liver Disease"
Alexander Miethke, MD and Stacey Huppert, PhD
"FIC1 Disease Modeling Using Induced Pluripotent Stem Cells"